UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

Breast cancer research and treatment, 2019-04, Vol.174 (2), p.433-442

2019

Volltextzugriff (PDF)

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

Osteoporosis international, 2012-11, Vol.23 (11), p.2567-2576

2012

Volltextzugriff (PDF)

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET

Annals of oncology, 2024-06, Vol.35 (6), p.549-558

2024

Volltextzugriff (PDF)

BTcP: Retrospective study on integrated hospital care between palliative care clinical and oncologist

Annals of oncology, 2017-10, Vol.28, p.vi102-vi102

2017

Volltextzugriff (PDF)

Prevention of colorectal adenomas

Colorectal disease, 2015-01, Vol.17 (s1), p.20-24

2015

Volltextzugriff (PDF)

Abstract ES3-3: Low dose tamoxifen and other approaches to improve chemoprevention uptake

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.ES3-3-ES3-3

De Censi, A

2020

Volltextzugriff (PDF)

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme

BJU international, 2019-01, Vol.123 (1), p.98-105

2019

Volltextzugriff (PDF)

Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS

Breast (Edinburgh), 2019-03, Vol.44, p.S6

2019

Volltextzugriff (PDF)

SA 4.3 - Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS

Breast (Edinburgh), 2019-03, Vol.44, p.S6-S6

2019

Volltextzugriff (PDF)

221P Early prediction of efficacy of endocrine therapy (ET) in metastatic breast cancer (MBC): Pilot study with [18F]fluoro-estradiol-17β (18F-FES) PET/CT

Annals of oncology, 2022-09, Vol.33, p.S639

2022

Volltextzugriff (PDF)

Abstract P3-10-02: Presence of atypia in ductal lavage and risk of subsequent breast cancer in a prospective study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-10-02

2018

Volltextzugriff (PDF)

Role of traditional and new biomarkers in breast carcinogenesis

Ecancermedicalscience, 2009-01, Vol.3, p.157

2009

Volltextzugriff (PDF)

A survey among breast cancer specialists on the low uptake of breast cancer preventive therapy with tamoxifen or raloxifene

Annals of oncology, 2016-10, Vol.27, p.vi462-vi462

2016

Volltextzugriff (PDF)

Abstract P4-15-06: Low dose tamoxifen lowers recurrences after mastectomy for in situ neoplasia. Ten-year results of a monoinstitutional study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P4-P4-15-06

2018

Volltextzugriff (PDF)

LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

Annals of oncology, 2020-09, Vol.31, p.S1161-S1161

2020

Volltextzugriff (PDF)

Multicenter, randomized, phase II, double-blind trial of a combination of anthocyanins and curcumin for colon cancer prevention in subjects with colorectal adenoma. The MIRACOL study

Annals of oncology, 2015-10, Vol.26, p.vi151

2015

Volltextzugriff (PDF)

Phase II randomised clinical study of metformin plus chemotherapy vs chemotherapy alone in HER2 negative metastatic breast cancer: final results of the MYME trial

Annals of oncology, 2016-10, Vol.27, p.vi70-vi70

2016

Volltextzugriff (PDF)

Dose-dence adjuvant chemotherapy in early breast cancer: the results of 15 years of follow-up

Annals of oncology, 2016-09, Vol.27, p.iv61

2016

Volltextzugriff (PDF)

Public Health Genomics in Cancer

European journal of public health, 2016-11, Vol.26 (suppl_1)

2016

Volltextzugriff (PDF)

Dose-dense adjuvant chemotherapy, treatment-induced amenorrhea and overall survival in premenopausal breast cancer patients: a pooled analysis of the MIG1 and GIM2 phase 3 studies

Annals of oncology, 2016-09, Vol.27, p.iv59

2016

Volltextzugriff (PDF)

1361PLONG-TERM EFFECTS OF INHALED BUDESONIDE ON SCREENING-DETECTED LUNG NODULES

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv478-iv478

2014

Volltextzugriff (PDF)

Long-Term Effects of Inhaled Budesonide on Screening-Detected Lung Nodules

Annals of oncology, 2014-09, Vol.25, p.iv478

2014

Volltextzugriff (PDF)

MA 02.05 Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1804-S1804

2017

Volltextzugriff (PDF)

Abstract P6-09-01: Breast Cancer Incidence and Hormonal Infertility Treatments: A Systematic Review of Population Studies

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P6-P6-09-01

2010

Volltextzugriff (PDF)

1 – 25 von 310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(274)
Mit Volltextzugriff
(274)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET

BTcP: Retrospective study on integrated hospital care between palliative care clinical and oncologist

Prevention of colorectal adenomas

Abstract ES3-3: Low dose tamoxifen and other approaches to improve chemoprevention uptake

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme

Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS

SA 4.3 - Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS

221P Early prediction of efficacy of endocrine therapy (ET) in metastatic breast cancer (MBC): Pilot study with [18F]fluoro-estradiol-17β (18F-FES) PET/CT

Abstract P3-10-02: Presence of atypia in ductal lavage and risk of subsequent breast cancer in a prospective study

Role of traditional and new biomarkers in breast carcinogenesis

A survey among breast cancer specialists on the low uptake of breast cancer preventive therapy with tamoxifen or raloxifene

Abstract P4-15-06: Low dose tamoxifen lowers recurrences after mastectomy for in situ neoplasia. Ten-year results of a monoinstitutional study

LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

Multicenter, randomized, phase II, double-blind trial of a combination of anthocyanins and curcumin for colon cancer prevention in subjects with colorectal adenoma. The MIRACOL study

Phase II randomised clinical study of metformin plus chemotherapy vs chemotherapy alone in HER2 negative metastatic breast cancer: final results of the MYME trial

Dose-dence adjuvant chemotherapy in early breast cancer: the results of 15 years of follow-up

Public Health Genomics in Cancer

Dose-dense adjuvant chemotherapy, treatment-induced amenorrhea and overall survival in premenopausal breast cancer patients: a pooled analysis of the MIG1 and GIM2 phase 3 studies

1361PLONG-TERM EFFECTS OF INHALED BUDESONIDE ON SCREENING-DETECTED LUNG NODULES

Long-Term Effects of Inhaled Budesonide on Screening-Detected Lung Nodules

MA 02.05 Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)

Abstract P6-09-01: Breast Cancer Incidence and Hormonal Infertility Treatments: A Systematic Review of Population Studies

Suchergebnisse filtern